Your browser doesn't support javascript.
loading
Serosurveys to detect SARS-CoV-2 antibodies among high-risk groups in six urban cities of Odisha, India.
Kanungo, Srikanta; Giri, Sidhartha; Bhattacharya, Debdutta; Kshatri, Jaya Singh; Palo, Subrata Kumar; Parai, Debaprasad; Turuk, Jyotirmayee; Praharaj, Ira; Mansingh, Asit; Dash, Girish Chandra; Choudhary, Hari Ram; Pattnaik, Matrujyoti; Barik, Shakti Ranjan; Mohanta, Amiya Ranjan; Swain, Aparajita; Mohapatra, Ira; Sahoo, Rakesh Kumar; Mishra, Rudra Prasanna; Patro, Sithun Kumar; Satapathy, Durga Madhab; Pati, Sanghamitra.
Affiliation
  • Kanungo S; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Giri S; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Bhattacharya D; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Kshatri JS; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Palo SK; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Parai D; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Turuk J; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Praharaj I; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Mansingh A; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Dash GC; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Choudhary HR; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Pattnaik M; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Barik SR; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Mohanta AR; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Swain A; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Mohapatra I; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Sahoo RK; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Mishra RP; Employee's State Insurance Corporation (ESIC) Hospital, Rourkela, Odisha, India.
  • Patro SK; Department of Community Medicine, Maharaja Krushna Chandra Gajapati (MKCG) Medical College and Hospital, Berhampur, Odisha, India.
  • Satapathy DM; Department of Community Medicine, Maharaja Krushna Chandra Gajapati (MKCG) Medical College and Hospital, Berhampur, Odisha, India.
  • Pati S; ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
J Infect Dev Ctries ; 17(9): 1255-1261, 2023 09 30.
Article in En | MEDLINE | ID: mdl-37824363
ABSTRACT

INTRODUCTION:

Personnel involved in essential services or residing in high-risk areas during the COVID-19 pandemic are at increased risk of getting infected. We evaluated the proportion of personnel infected in several high-risk groups in Odisha using seroprevalence studies.

METHODOLOGY:

During July to November, 2020, individuals from multiple high-risk groups in 6 urban cities (Bhubaneswar, Berhampur, Cuttack, Malkangiri, Paralakhemundi, and Rourkela) in Odisha, India, were recruited to the study after obtaining written informed consent. Blood samples collected from the study participants were tested for IgG antibodies against COVID-19 in Roche Cobas e441 (Roche Diagnostics, Rotkreuz, Switzerland). Information on socio-demographic variables, association with a confirmed or suspected case, and other details were collected using an electronic data capture tool and analysed with a statistical software.

RESULTS:

The overall COVID-19 seroprevalence was 34.9% (95%CI 33.6-36.2) among the 5434 individuals. The seroprevalence varied from 21.8% (95% CI, 19.6-24.1) in Rourkela to 54.9% (95% CI, 51.5-58.2) in Bhubaneswar. Seropositivity was maximum among prisoners (47.7%), followed by municipality/ sanitation staff (43.5%), and other office going staff (40.8%). Multivariate logistic regression indicated that participants aged 18-29 years, 30-44 years, residents of slums and vending zone, municipality staff, prisoners, residents of urban cities Malkangiri, Cuttack, Paralakhemundi, Bhubaneswar and those with previous history of COVID-19 were independent co-relates of seropositivity.

CONCLUSIONS:

The risk of COVID-19 varied among the high-risk groups of Odisha. Periodic seroprevalence studies in future are essential to protect the high-risk personnel involved in frontline activities during the pandemic.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Humans Country/Region as subject: Asia Language: En Journal: J Infect Dev Ctries Journal subject: DOENCAS TRANSMISSIVEIS Year: 2023 Document type: Article Affiliation country: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Humans Country/Region as subject: Asia Language: En Journal: J Infect Dev Ctries Journal subject: DOENCAS TRANSMISSIVEIS Year: 2023 Document type: Article Affiliation country: India